key: cord-0777827-wgg6nzi2
authors: Li, Bing; Zheng, Junqing
title: MicroR‐9‐5p suppresses EV71 replication through targeting NFκB of the RIG‐I‐mediated innate immune response
date: 2018-08-29
journal: FEBS Open Bio
DOI: 10.1002/2211-5463.12490
sha: 620c2d071dd49eb5bcc31f378eb219310e4b1ebc
doc_id: 777827
cord_uid: wgg6nzi2

Accumulating evidence demonstrates that there is a causative link between hsa‐microRNA‐9‐5p (miR‐9) and pathophysiological processes. Enterovirus 71 (EV71) has been found to contribute to numerous severe clinical symptoms which result in death. The exact mechanism by which EV71 influences miR‐9 expression is unknown, and the relationship between miR‐9 and EV71 is still unclear. Here, miR‐9 expression was found to be impaired upon EV71 infection in several cell lines and in an EV71 infection mouse model. Additionally, we confirmed that EV71 infection induces robust expression of pro‐inflammatory cytokines (TNF‐α, IL‐6, and IL‐1) and interferons (IFN‐α and IFN‐β). Overexpression of miR‐9 attenuated EV71 proliferation and reduced protein and gene expressions of virion protein 1 (VP1) of EV71. Furthermore, we observed that the inflammation caused by EV71 infection was restored to a moderate level via miR‐9 overexpression. Nuclear factor kappa B (NFκB) in the retinoic acid‐induced gene 1 (RIG‐I) signaling pathway, but not interferon regulating factor 3 (IRF3), was significantly decreased and inactivated by ectopic miR‐9 expression. Moreover, in mouse infection experiments, administration of miR‐9 agomirs caused a significant decrease in VP1 levels and pro‐inflammatory cytokine production after viral inoculation. Taken together, the present data demonstrate that miR‐9 exerts an anti‐EV71 effect in cells and a mouse model via mediating NFκB activity of the RIG‐I signal pathway, thereby suggesting a new candidate for antiviral drug development.

Accumulating evidence demonstrates that there is a causative link between hsa-microRNA-9-5p (miR-9) and pathophysiological processes. Enterovirus 71 (EV71) has been found to contribute to numerous severe clinical symptoms which result in death. The exact mechanism by which EV71 influences miR-9 expression is unknown, and the relationship between miR-9 and EV71 is still unclear. Here, miR-9 expression was found to be impaired upon EV71 infection in several cell lines and in an EV71 infection mouse model. Additionally, we confirmed that EV71 infection induces robust expression of pro-inflammatory cytokines (TNF-a, IL-6, and IL-1) and interferons (IFN-a and IFN-b). Overexpression of miR-9 attenuated EV71 proliferation and reduced protein and gene expressions of virion protein 1 (VP1) of EV71. Furthermore, we observed that the inflammation caused by EV71 infection was restored to a moderate level via miR-9 overexpression. Nuclear factor kappa B (NFjB) in the retinoic acid-induced gene 1 (RIG-I) signaling pathway, but not interferon regulating factor 3 (IRF3), was significantly decreased and inactivated by ectopic miR-9 expression. Moreover, in mouse infection experiments, administration of miR-9 agomirs caused a significant decrease in VP1 levels and pro-inflammatory cytokine production after viral inoculation. Taken together, the present data demonstrate that miR-9 exerts an anti-EV71 effect in cells and a mouse model via mediating NFjB activity of the RIG-I signal pathway, thereby suggesting a new candidate for antiviral drug development.

Hand, foot, and mouth disease (HFMD) is a viral infection commonly occurring in children and infants, which produces flu-like symptoms and blisters [1] [2] [3] . HFMD is caused by enteroviruses [e.g., coxsackievirus A16 and enterovirus 71 (EV71)] [4] [5] [6] . EV71 is a single-stranded positive-sense RNA virus belonging to the Enterovirus genus of the Picornaviridae family [7, 8] . Infection by EV71 in children is related to severe neurological, pulmonary, and gastrointestinal dysfunctions. It has been suggested that disease severity is additionally affected by host factors, such as the host immune response [9] . The severity of EV71 infection has been found to be related to excessive and robust pro-inflammatory chemokine and cytokine responses and production [10] . The innate immune system affords defense against invading pathogens at an early phase of infection by recognizing various conserved pathogen-associated molecular patterns (PAMPs), including viral RNAs, and acting to limit virus replication. RLRs (RIG-I-like receptors) [11] , TLRs (Toll-like receptors) [12] , and NOD-like receptors [13] are members of PRRs (pattern recognition receptors), which can recognize viral RNA and elicit downstream signal transduction to provoke the innate immune response. Innate immunity is utilized by the host to fight against foreign pathogens, and EV71 invasion triggers the RLR and TLR pathways to counter the duplication and spreading of the virus. RIG-I, an essential receptor that recognizes EV71 RNA, engages in cytokine production in the host. RIG-I releases the N-terminal caspase-recruitment domain (CARD) for interaction with an identical domain on the adaptor protein located on the outer membrane of mitochondria after it interacts with viral RNAs [14] , and consequently activates nuclear factor kappa B (NFjB) and interferon regulating factor 3/7 (IRF3/7). Phosphorylation of NFjB and IRF3/7 induces production of pro-inflammatory cytokines, chemokines, interferon (IFN), and adhesion molecules against pathogen invasion. However, the hyperinduction of pro-inflammatory cytokines induced by pathogen infection, such as tumor necrosis factor (TNF)-a, interleukin (IL)-1, and IL-6 (i.e., a cytokine storm), causes complications or even ultimately death as a result of these infections [15] .

The microRNAs (miRs) belong to a group of small noncoding RNAs, which were first identified in C. elegans in 1993 [16] . Previous reports demonstrated that miRs function in many pathological and biological processes, including inflammation and viral infection [17] [18] [19] [20] [21] [22] . Micro-RNAs additionally play an essential role in EV71 infection and modulating viral replication and pathogenicity [23] [24] [25] . In our study, we found that EV71 infection downregulated the expression of miR-9. Ectopic expression of miR-9 with EV71 infection induced an RLR-triggered innate immune response and pro-inflammatory cytokine production. Moreover, miR-9 agomirs were able to limit EV71 replication by maintaining cytokines at a moderate level in different tissues in animal model. Notably, our data reveal that miR-9 significantly decreased EV71-induced excessive production of pro-inflammatory cytokines through reducing expression and activation of NFjB. Given these results, our data demonstrate that miR-9 positively regulates inflammation elicited by EV71 and suppresses virus replication by targeting NFjB.

Human embryonic kidney (HEK) 293T cells, human rhabdomyosarcoma cells (RD), human cervical carcinoma cells (HeLa), human colorectal cells (HT-29), Vero cells, and human monocytes (THP-1) were obtained from ATCC (Manassas, VA, USA) and maintained in Dulbecco's modified Eagle's medium (DMEM; Gibco, Shanghai, China) supplemented with 2% penicillin/streptomycin and 10% (v/ v) fetal bovine serum (FBS; Gibco) at 5% CO 2 and 37°C. This work was approved by Jinan Maternity and Child Care Hospital.

Enterovirus 71 (Shenzhen strain, GenBank accession number AF30299.1) infection was performed as follows. Vero cells were used to produce human EV71. Briefly, Vero cells were seeded into a dish prior to infection. EV71 was dispersed in DMEM, followed by inoculation to Vero cells (approximately 80% confluence). We added DMEM supplemented with 2% FBS, and the infection was allowed to proceed until the monolayer showed cytopathic effects (CPE). The culture medium and cells were harvested and subjected to three freeze-thaw cycles. Tenminute centrifugation at 4500 g was performed, and the supernatant was transferred into cryovials and stored at À80°C.

The 50% tissue culture infectious dose (TCID 50 )/mL titration was determined for the virus as follows. Briefly, we seeded~5000 RD cells/well in a 96-well plate. DMEM supplemented with FBS (2%; 10 3 to 10 8 dilution) was used to dilute the virus, and each dilution was added in separate wells. The plates underwent incubation at 5% CO 2 and 37°C for 2 to 5 days. Using microscopy, CPE was analyzed. Reed-M€ unch endpoint calculation was employed to determine TCID 50 .

Enterovirus 71 infection of 293T, Vero, RD, HT-29, HeLa, and THP-1 cells was performed. Specifically, EV71 was inoculated into monolayer cells at approximately 50% confluence at a multiplicity of infection (MOI) of 1-10 TCID 50 /cell. After 1 h of adsorption in an incubator at 37°C and 5% CO 2 , culture medium without FBS was used to wash the cells to remove free virus. Then, fresh culture medium supplemented with FBS (10%) was added. Cells were harvested for further examination at the indicated time points.

Pregnant mice (ICR) were provided by Vital River (Beijing, China). All of the mice were raised in a pathogen-free room with separate ventilation cage systems. The mice were aged for two weeks and then were infected with either sterile PBS or EV71 at the dose of 10 5 TCID 50 /mouse via an intraperitoneal route. Disease manifestations and weight were observed and recorded every day following infection. The animals were sacrificed four or five days after posterior paralysis appeared. Muscle tissue, spleen, heart, lung, brain, kidney, small intestine, and whole blood were harvested, and RNA was extracted.

All experiments followed the institutional guidelines for animal research, and approval was obtained from the Ethics Committee of the Jinan Maternity and Child Care Hospital.

Anti-VP1 (from Shenzhen strain, bs-2297R), monoclonal anti-b-actin (ab8227), anti-RIG-I (sc-376845), anti-IL-1 (ab9722), anti-IFN-b (ab151605), and anti-NFjB (ab16502), anti-IRF3 (ab25950), anti-phospho-NFjB (ab86299), and anti-phospho-IRF3 (ab192796) antibodies were purchased from Abcam (CA, USA) and Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA) to detect the indicated protein by western blotting. Goat anti-rabbit IgG conjugated to TRITC (tetramethyl rhodamine isothiocyanate) secondary antibodies was purchased from Zhongshan Golden Bridge Biotechnology (Beijing, China) and was used for immunofluorescence assay (IFA).

Cells were lysed in RIPA buffer (pH 8.0, 50 mM Tris/HCl, 150 mM NaCl, 1% NP-40, 0.1% SDS) containing a protease inhibitor cocktail. The BCA Protein Quantitation Kit was used to determine the protein concentration. SDS/ PAGE (10%) was used to separate protein samples (20 lL, 1 mgÁmL À1 ), which were then electrically transferred onto Immobilon PVDF membranes (0.45 lm). The membranes were then blocked with BSA (bovine serum albumin; 5%) in PBST (0.5% Triton X-100 added in PBS) at room temperature for 1 h, followed by overnight incubation at 4°C with the following antibodies: rabbit anti-VP1 (1 : 2500), anti-RIG-I (1 : 5000), anti-IRF3 (1 : 1000), mouse antiphospho-IRF3 (1 : 500), anti-NFjB (1 : 2000), anti-phospho-NFjB (1 : 500), and anti-b-actin (1 : 2500). Then, Amersham ECL peroxidase-linked goat anti-mouse IgG or anti-rabbit IgG secondary antibodies were incubated with the membranes for 1 h at 25°C. The C-DiGit Blot Scanner and SuperSignal West Femto Maximum Sensitivity Substrate Kit (Thermo Fisher Scientific, Waltham, MA, USA) were used to detect western blot immunoreactivity.

Total RNA was extracted from the cells after the indicated treatments using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. The levels of mRNA were determined using SYBR Green Master Mix (4385618; Thermo Fisher Scientific) incorporation on a Roche LightCycler 480 Real-Time PCR system (Roche, Basel, Switzerland), and GAPDH was used as the internal control. The sequences of the primers used are shown in Table 1 .

Quantitative real-time PCR was performed in 20 lL volumes using the SYBR Green PCR Master Mix in the Light-Cycler 480 with the following conditions: 95°C for 10 min, then 40 cycles of 95°C for 15 s, 60°C for 30 s, and 72°C for 30 s. The level of each mRNA (2 ÀDDCT ) was calculated through normalization to the endogenous reference and relative to the calibrator (the mean of the control samples).

Virus infection of RD cells grown in 24-well plates with cover slides was performed at an MOI of 0.1 TCID 50 /cell. Paraformaldehyde (4%) in PBS was used to fix the cells for 1 h at room temperature. Ten-minute permeabilization of the cells with PBST was performed at 25°C, followed by a 1-h incubation with PBST (including 0.4% BSA) at 37°C and a subsequent 1-h incubation with polyclonal anti-VP1 antibody, which was diluted in PBST (including 0.2% BSA) at 37°C. Following a 1-h PBST wash, the cells underwent 1-h incubation with TRITC-labeled goat anti-rabbit antibody diluted in 0.2% BSA and PBST at 37°C. Next, cells were washed for 1 h with PBST. DAPI was used to stain the Table 1 . Primer sequences.

Full name Abbreviation nuclei of the cells. A confocal laser scanning fluorescence microscope (Olympus LSCMFV500, Olympus, Tokyo, Japan) was employed to analyze VP1 staining in cells.

miR-9-mimic and miR-9 agomir preparation miR-9-mimic and a scramble control, NC-mimic, were purchased from Genscript (Shanghai, China). miR-9mimic is an artificial, chemically modified double-stranded miRNA, which mimics the mature endogenous miR-9 after being transfected into cells with concentration of 100 lgÁmL À1 . Both miR-9-mimic and NC-mimic were suspended in 0.9% NaCl to a final storage concentration of 10 mgÁmL À1 . The miR-9 agomir is a double-stranded RNA analog of mature miR-9 which has been chemically modified and conjugated to a cholesterol moiety to promote specificity and stability for assays. For treatment in vivo, agomiR-9 (RiboBio, Guangdong, China) was injected intravenously into the tail vein at a dose of 1 nmol (diluted in 20 lL PBS) per mouse three days before EV71 infection.

The potential targets of miR-9 were identified by combining algorithms using miRDB (http://www.mirdb.org). The targets predicted by these algorithms were analyzed, and the candidates were selected according to the function.

Amplification of the 3 0 -UTR of the NFjB gene was performed, which was inserted into the GV126 luciferase gene. The binding sites for miR-9 on the NFjB gene were destroyed by mutagenesis, and the mutants were selected as controls. The transfection efficiency was adjusted by the thymidine kinase promoter (pRL-TK vector; TaKaRa, Beijing, China) and the Renilla luciferase gene, which contained the plasmid. Cotransfection of miR-9-mimic and NC-mimic into the luciferase reporter vector was conducted for different cell lines with Lipo2000 transfection reagent. The luciferase assay was performed according to the manufacturer's instructions. Myllicin (to avoid any possibility of the fungal and/or bacterial infection during handling the experiments) was added into the cell culture in DMEM (supplemented with 10% FBS), followed by incubation at 5% CO 2 and 37°C. The medium was changed every two days. Then, 0.25% trypsin was used to detach the cells, followed by subculture when the cells reached~70-80% confluency.

The data are presented as the mean AE standard deviation. Two-tailed Student's t-test was employed for comparison.

Values of P < 0.05 were considered statistically significant: *P < 0.05; **P < 0.01; and ***P < 0.001.

The miR-9 expression in 293T, Vero, RD, HT-29, HeLa, and THP-1 cells was examined at 24 h after EV71 infection. Virion protein 1 (VP1) expression was found to be markedly increased in each of these six cell lines after EV71 infection at both the protein and mRNA levels (Fig. 1A,B) , indicating the successful infection by EV71. We then found that miR-9 expression was significant decreased after EV71 infection in all cell lines, especially in RD cells. Next, EV71-infected mice were utilized to examine miR-9 expression in vivo. The EV71 was injected into the abdomen of the mice, which were sacrificed either four or five days following appearance of severe posterior paralysis. Real-time PCR analysis revealed that the virus mainly localized to the lung and muscle (Fig. 1C ). There were relatively low titers of EV71 in the spleen, brain, liver, and intestine. The expression level of miR-9 in different tissues was then examined. We observed a significant decrease in miR-9 expression in muscle, intestine, lung, and brain (Fig. 1D) . Taken together, these data demonstrate that EV71 mainly replicates in muscle. The downregulation of miR-9 in muscle induced by EV71 infection was verified by real-time PCR (Fig. 1E) .

To confirm whether EV71 infection causes robust production of pro-inflammatory cytokines, real-time PCR and western blotting were conducted to assess the expression of IL-1, IL-6, TNF-a, IFN-b, and IFN-a at the protein and mRNA levels after EV71 infection of human colorectal, Vero, and rhabdomyosarcoma cells. As Fig. 2A shows, IL-1 and IFN-b expression in three cell lines was significantly increased in the EV71infected group. Real-time PCR data further confirmed that IL-1, IL-6, TNF-a, IFN-a, and IFN-b mRNA levels were significantly elevated after EV71 infection, especially in RD cells (Fig. 2B) . Next, the EV71infected mouse model was utilized to evaluate relative IL-1 and IFN-a expression in several tissues. As expected, excessive production of cytokines was observed in muscle and lung tissue (Fig. 2C) . These data clearly demonstrate that EV71 invasion induces pro-inflammatory cytokine production in vitro and in vivo. 

After human colorectal, Vero, and rhabdomyosarcoma cells were infected with EV71 and/or transfected with miR-9-mimic, multiple growth curves were determined to assess the influence of miR-9 on EV71 replication. As shown in Fig. 3A , the viral growth rate was significantly reduced by 10 2 -to 10 5 -fold in miR-9-mimictreated cells. The virion protein 1 (VP1) was examined at the protein and mRNA levels at the indicated time points. As shown in Fig. 3B , VP1 expression was significantly decreased by miR-9-mimic transfection, especially in RD cells, in which its expression pattern was markedly reduced. The decrease in viral protein was consistent with real-time PCR results, which showed that the mRNA level of VP1 was significantly reduced in the miR-9-mimic-treated group compared with the nontreated group (Fig. 3C) . We then performed IFA to visualize the VP1 in the infected RD cells. As shown in Fig. 3D , the level of VP1 in EV71-infected cells treated with miR-9-mimic was significantly less than that in the nontreated group. These results suggest that miR-9 significantly decreased the viral titers of EV71 in different cell lines.

To confirm the effect of miR-9 on pro-inflammatory cytokine production at the cellular level, real-time PCR was performed to evaluate the level of cytokines and interferon. Importantly, we found that three essential cytokines in EV71-infected cells, IL-1, IL-6, and TNF-a, were gradually induced at different stages of infectious cycle. However, their expressions were kept at a moderate level at the examined time points postinfection in the miR-9-mimic-treated group (Fig. 4A) . Furthermore, these cytokines in RD cells were examined by western blotting. In the EV71-infected group, cytokine expression significantly increased, but their production was clearly suppressed by miR-9 expression (Fig. 4B) . These results indicate that miR-9 ameliorated the robust cytokine storm induced by EV71 at the later stage of infection.

Enterovirus 71 viral infection can induce multiple innate immune signaling pathways, especially the RIG-I-like receptor (RLR) pathway. To determine whether the RIG-I pathway plays an essential role in the miR-9-regulated host innate immune response to EV71 infection, analysis of RIG-I and two key sensors (IRF3 and NFjB) was performed at the transcriptional and translational levels after EV71 infection and/or miR-9-mimic treatment (Fig. 5A) . Protein expression of both IRF3 and RIG-I in miR-9-mimicexpressing cells did not show a significant difference with nontransfected cells. However, NFjB expression decreased after miR-9-mimic transfection compared to cells only induced by EV71. Additionally, phosphorylated NFjB, which is an indication of activated NFjB, was reduced, but phosphorylated IRF3 was not. Consistent with these results, real-time PCR data suggested more efficient downregulation of NFjB was observed in RD cells treated with miR-9-mimic, while lower NFjB was detected in the miR-9-mimic-treated group, compared to the nontreated group (Fig. 5B) . Together, these data demonstrate that miR-9 regulates inflammation production via the RIG-I signal pathway.

Bioinformatics analysis has identified NFjB, which is a key immune sensor for the RLR innate immune response against EV71 infection, as a functional putative miR-9 target (Fig. 6A) . A dual-luciferase reporter assay was conducted in six cell lines (293T, Vero, RD, HT-29, HeLa, and THP-1) to investigate direct binding between NFjB and miR-9. The data show that miR-9-mimic transfection decreased the luciferase activity of the reported fused with the NFjB 3 0 -UTR (Fig. 6B) . Furthermore, we examined the NFjB expression in the six cell lines infected with EV71 and/ or transfected with miR-9-mimic, using real-time PCR and western blotting. As shown in Fig. 6C ,D, the NFjB expression was suppressed because of miR-9mimic expression at both the protein and mRNA levels.

To further probe the mechanism of how miR-9 agomir administration attenuates EV71 replication and pathogenicity in an animal model, we performed realtime PCR to assess VP1 and cytokine levels. As shown in Fig. 7A , miR-9 was confirmed to be ectopically expressed by real-time PCR. Additionally, we found that VP1 expression was significantly reduced after miR-9 agomir administration, suggesting an antiviral effect of miR-9. Furthermore, the levels of the proinflammatory cytokines induced by EV71 were evaluated by real-time PCR experiment (Fig. 7B ). As shown in Fig. 7C ,D, robust expression of IL-1 and IFN-b was observed in muscle, lung, blood, and spleen tissues of EV71-infected mice. In contrast, the expression of these two cytokines was markedly inhibited with agomiR-9 treatment. Together, our data provide evidence that miR-9 confers an inhibitory effect on the EV71-induced cytokine storm and therefore ameliorates the damage caused by EV71.

In this study, an inhibitory role of miR-9 in replication and pathogenicity of EV71 infection was observed both in vitro and in vivo. The expression pattern of viral EV71 protein was decreased by miR-9 treatment. Furthermore, we found that miR-9 was able to ameliorate the robust innate immune response against EV71 at different stages of infection by targeting the immune sensor NFjB and decreasing its expression.

Increasing evidence has demonstrated that excessive inflammatory signaling occurring during organ injury is one of the main pathogenic factors responsible for high mortality following EV71 infection [26] [27] [28] . NFjB is a signaling pathway that regulates many genes related to cell differentiation, proliferation, and innate immune response. In addition, via eliciting pro-inflammatory cytokine and type I IFN (IFN-b and IFN-a) expression, NFjB is important in the antiviral reactions of the host [29] [30] [31] . However, the 2C protein of EV71 suppresses NFjB activation, which increases the virus replication. Viral protein 2C suppresses the phosphorylation of IjBa and IKKb via binding with their kinase domains, reducing NFjB activation, and promoting viral replication The luciferase activity of the luciferase reporter constructs containing either the wild-type or mutated 3 0 -UTR of human NFjB after miR-9-mimic transfection in several cell lines. The luciferase activity was normalized to the activity of b-galactosidase. miR-9 overexpression significantly decreased the relative luciferase activity in the wild-type 3 0 -UTR, but not mutant 3 0 -UTR of NFjB mRNA. (C and D) Western blotting and real-time PCR analysis were performed to determine the levels of NFjB protein and mRNA after miR-9-mimic transfection or control. These assays have been performed three times. Data represent means AE SD. *P < 0.05; **P < 0.01; ***P < 0.001. The statistical test performed using Student's t-test. 7 . Effect of miR-9 on EV71 replication and pathogenicity in mice. Mice were inoculated with EV71 or PBS as a negative control. Mice were then treated with miR-9 agomir. (A) Mice from the EV71 group and the NC group were sacrificed on day 4 or 5 postinoculation to determine miR-9 expression in different tissues of mice. Expression levels of VP1 (B), IL-1 (C), and IFN-b (D) in different tissues of EV71infected mice were examined using real-time PCR. These assays have been performed three times. Data represent means AE SD. *P < 0.05; **P < 0.01; ***P < 0.001. The statistical test performed using Student's t-test. [32]. In our study, miR-9 administration resulted in deactivation and expression of NFjB while inhibiting EV71 replication. These results could be attributed to the robust pro-inflammatory cytokines, which are believed to contribute to EV71 pathogenicity, which were ameliorated by miR-9 expression, indicating that a moderate level of cytokines and interferon was maintained to limit the effect of EV71. However, the molecular mechanisms by which miR-9 controls VP1 expression and viral replication during EV71 infection still need further research to investigate the possibility of whether miR-9 inhibits inflammation and EV71 propagation separately.

The practical implication of miR-9 in evolution is suggested by its sequence conservation at the nucleotide level in different species rather than its varying expression patterns. Although the sequence of miR-9 is conserved, its expression profile differs significantly in various species. miR-9 is being extensively investigated in various biological processes: NPC proliferation and migration [33] , neuronal differentiation [34] , apoptotic cell death [35] , brain function and neurodegeneration [36] , and cancer [37] . Moreover, accumulating evidence suggests that miR-9 is required for replication of multiple of viruses. Dong et al. [38] indicated a novel function of miR-9 in influenza A virus infection and found that the influenza virus might hijack endogenous miR-9 for the viral life cycle. Tatro et al. [39] suggested that HIV infection induced elevated expression of miR-9, causing suppression of splice variants of KCNMA1, which may affect the release of neurotransmitters. Lai et al. reported that the nucleocapsid protein of human coronavirus OC43 causes activation of NFjB. This activation was the consequence of the nucleocapsid binding to RNA, specifically miR-9 (a negative NFjB modulator), as was found in this study [40] . Our study suggests that miR-9 is a negative mediator for EV71 replication in vitro and in vivo. Ectopic expression of miR-9 in cells resulted in inactivation of NFjB and ameliorated the excessive cytokine production, potentially lessening the organ injury induced by the cytokine storm during virus infection.

Our data imply that antiviral activity of miR-9 is related to regulation of the release of pro-inflammatory cytokines through RIG-I signal transduction via decreasing the activity and expression of NFjB. This study may provide new insights into EV71 infection suppression.

Beta-actin variant is necessary for Enterovirus 71 replication

Recent advances in the molecular epidemiology and control of human enterovirus 71 infection

Receptors identified for hand, foot and mouth virus

Human enterovirus 71 and hand, foot and mouth disease

Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E

Viral and host factors that contribute to pathogenicity of enterovirus 71

Clinical features of severe cases of hand, foot and mouth disease with EV71 virus infection in China

Unusual skin manifestation of hand, foot and mouth disease associated with coxsackievirus A6: cases report

Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in Taiwan

enterovirus 71 infections of the central nervous system

Inflammatory response of mast cells during influenza A virus infection is mediated by active infection and RIG-I signaling

Toll-like receptor pre-stimulation protects mice against lethal infection with highly pathogenic influenza viruses

Inflammasome Is Protective in Juvenile Influenza A Virus Infection

Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3

Influenza virus pathogenicity regulated by host cellular proteases, cytokines and metabolites, and its therapeutic options

The C (1993) elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

MicroRNA-155 promotes atherosclerosis inflammation via targeting SOCS1

Fortunellin-induced modulation of phosphatase and tensin homolog by MicroRNA-374a decreases inflammation and maintains intestinal barrier function in colitis

MicroRNA-22 regulates inflammation and angiogenesis via targeting VE-cadherin

MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation

microRNA-140 inhibits inflammation and stimulates chondrogenesis in a model of interleukin 1beta-induced osteoarthritis

MicroRNA-146a ameliorates inflammation via TRAF6/NF-kappaB pathway in intervertebral disc cells

Different microRNA alterations contribute to diverse outcomes following EV71 and CA16 infections: Insights from highthroughput sequencing in rhesus monkey peripheral blood mononuclear cells

Different microRNA profiles reveal the diverse outcomes induced by EV71 and CA16 infection in human umbilical vein endothelial cells using high-throughput sequencing

MicroRNA-23b inhibits enterovirus 71 replication through downregulation of EV71 VPl protein

Enterovirus71 (EV71) utilise host microRNAs to mediate host immune system enhancing survival during infection

Exosome-mediated miR-146a transfer suppresses type I interferon response and facilitates EV71 infection

Innate immunity and immune evasion by enterovirus 71

NF-kappa B: ten years after

Activators and target genes of Rel/NF-kappaB transcription factors

Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses

Enterovirus 71 2C protein inhibits TNF-alpha-mediated activation of NF-kappaB by suppressing IkappaB kinase beta phosphorylation

MicroRNA-9 modulates Cajal-Retzius cell differentiation by suppressing Foxg1 expression in mouse medial pallium

MicroRNA-9 directs late organizer activity of the midbrain-hindbrain boundary

MicroRNA-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitors

Posttranscriptional regulation of BK channel splice variant stability by miR-9 underlies neuroadaptation to alcohol

MYC/MYCNactivated microRNA, regulates E-cadherin and cancer metastasis

Modulation of influenza A virus replication by microRNA-9 through targeting MCPIP1

Modulation of BK channel by MicroRNA-9 in neurons after exposure to HIV and methamphetamine

Human coronavirus OC43 nucleocapsid protein binds microRNA 9 and potentiates NF-kappaB activation

This work was supported by Research Fund of Jinan Maternity and Child Care Hospital.

In this work, BL and JZ conceived the study and designed the experiments, contributed to the data collection, performed the data analysis, and interpreted the results. BL wrote the manuscript and JZ contributed to the critical revision of article. Both authors read and approved the final manuscript.